Xcellerex
Pharmaceutical Manufacturing51-200 Employees
Xcellerex operates in pharmaceutical manufacturing and centers its offering on a biomanufacturing platform built around single-use component technology. The platform aims to shift biomanufacturing economics by enabling faster deployment of new manufacturing capacity—roughly 12 to 18 months versus 3 to 5 years—and by reducing upfront capital investment, typically by a substantial margin. It also provides flexibility through a modular environment designed for rapid redeployment across multiple drugs. To support adoption, Xcellerex offers a suite of products and services, including the XDR line of single-use bioreactors, PDMax high-throughput process development and optimization services, and GMP manufacturing operated by an experienced CMC team. The company targets biopharmaceutical developers and manufacturers seeking scalable, cost-efficient production options and greater production flexibility. In the pharmaceutical manufacturing industry, the firm positions itself as a mid-sized organization focused on enabling faster, lower-cost biomanufacturing workflows.
1-888-653-2347 
support@leadiq.com 
